06:00Paola Clauser, Vienna / AT, Bernd Hamm, Berlin / DE
2
AI-powered prostate cancer detection: a multi-centre, multi-scanner validation study
10:00Francesco Giganti, London / UK
3
Discussant
08:00Valdair Francisco Muglia, Ribeirao Preto / BR
4
Current use of percutaneous ablation in renal tumors: an analysis of the registry of the German Society for Interventional Radiology and Minimally Invasive Therapy (DeGIR) 2018-2023
10:00Benedikt Michael Schaarschmidt, Essen / DE
5
Discussant
08:00Thomas J. Kröncke, Augsburg / DE
6
How useful is contrast-enhanced MRI in the long-term surveillance of glioma? A multicentre retrospective longitudinal cohort study
10:00Marion Smits, Rotterdam / NL
7
Discussant
08:00Albert Pons Escoda, Barcelona / ES
8
Preoperative MRI for invasive lobular carcinoma is associated with a six-fold reduction of reoperations: a patient-matched analysis from the MIPA study
10:00Francesco Sardanelli, Milan / IT
9
Discussant
08:00Lígia Pires-Gonçalves, Porto / PT
6 min
Chairpersons' introduction
Bernd Hamm, Berlin / Germany Paola Clauser, Vienna / Austria
10 min
AI-powered prostate cancer detection: a multi-centre, multi-scanner validation study
Francesco Giganti, London / United Kingdom
8 min
Discussant
Valdair Francisco Muglia, Ribeirao Preto / Brazil
10 min
Current use of percutaneous ablation in renal tumors: an analysis of the registry of the German Society for Interventional Radiology and Minimally Invasive Therapy (DeGIR) 2018-2023
Benedikt Michael Schaarschmidt, Essen / Germany
8 min
Discussant
Thomas J. Kröncke, Augsburg / Germany
10 min
How useful is contrast-enhanced MRI in the long-term surveillance of glioma? A multicentre retrospective longitudinal cohort study
Marion Smits, Rotterdam / Netherlands
8 min
Discussant
Albert Pons Escoda, Barcelona / Spain
10 min
Preoperative MRI for invasive lobular carcinoma is associated with a six-fold reduction of reoperations: a patient-matched analysis from the MIPA study